NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION

Insurance INS

Rutledge v. Pharmaceutical Care Management Association; pet. for cert. granted, No.18-540 (U.S.)

Contacted: Health & Human Services, Dept of (HHS); Office of Natl Drug Control Policy (NDCP); Office of Management & Budget (OMB); Labor, Dept of (DOL); Substance Abuse & Mental Health Services Administration (SAMHSA); Small Business Administration (SBA); Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); White House Office; SENATE; Government Accountability Office (GAO); Drug Enforcement Administration (DEA)

Labor Issues/Antitrust/Workplace LBR

Final rule, "Defining and Delimiting the Exemptions for Executive, Administrative, Professional, Outside Sales and Computer Employees"; H.R. 6201, the Families First Coronavirus Response Act; H.R. 7528, the Get America Back to Work Act; S. 4317, the SAFE TO WORK Act;

Contacted: White House Office; Food & Drug Administration (FDA); SENATE; Labor, Dept of (DOL); Drug Enforcement Administration (DEA); Office of Natl Drug Control Policy (NDCP); Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES; Small Business Administration (SBA); Defense, Dept of (DOD); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Substance Abuse & Mental Health Services Administration (SAMHSA); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO)

Bills named: H.R. 6201 (116th), H.R. 7528 (116th), S. 4317 (116th)

Animals ANI

H.R. 1607, Fairness to Pet Owners Act of 2019

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); Labor, Dept of (DOL); White House Office; Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Government Accountability Office (GAO); Drug Enforcement Administration (DEA); Small Business Administration (SBA); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Defense, Dept of (DOD); Internal Revenue Service (IRS)

Bills named: H.R. 1607 (116th)

Defense DEF

Tricare pharmacy issues; S. 3932, the TRICARE Retail Pharmacy Prescription Medication Expansion Act; S. 4049, the National Defense Authorization Act for Fiscal Year 2021; H.R. 6395, the William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021

Contacted: White House Office; Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); Small Business Administration (SBA); Government Accountability Office (GAO); SENATE; Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD); Office of Natl Drug Control Policy (NDCP); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Substance Abuse & Mental Health Services Administration (SAMHSA); Internal Revenue Service (IRS); Food & Drug Administration (FDA)

Bills named: S. 4049 (116th), H.R. 6395 (116th), S. 3932 (116th)

Alcohol and Drug Abuse ALC

H.R. 127, CARERS Act of 2019; H.R. 171, the Legitimate Use of Medical Marihuana Act; H.R. 1845, ALERT Act of 2019; S. 516, Prescription Drug Monitoring Act of 2019; H.R. 1588, Ending Federal Marijuana Prohibition Act of 2019; Implementation of pharmacy provisions of Public Law No: 115-271; Implementation of Hemp provisions of Public Law No: 115-334; H.R. 4810, the Opioid Prescription Verification Act of 2019; S. 3070, the Preventing Pill Mills Through Data Sharing Act; HR 3878, the Block, Report, and Suspend Suspicious Shipments Act of 2019; HR 4812, the Ensuring Compliance Against Drug Diversion Act; HR 4814, the Suspicious Order Identification Act of 2019

Contacted: Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Small Business Administration (SBA); Office of Natl Drug Control Policy (NDCP); Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Substance Abuse & Mental Health Services Administration (SAMHSA); White House Office; Labor, Dept of (DOL); Food & Drug Administration (FDA); Internal Revenue Service (IRS); Government Accountability Office (GAO); SENATE

Bills named: H.R. 4814 (116th), H.R. 4812 (116th), H.R. 3878 (116th), H.R. 1588 (116th), H.R. 127 (116th), H.R. 4810 (116th), S. 3070 (116th), S. 516 (116th), H.R. 171 (116th), H.R. 1845 (116th)

Health Issues HCR

S. 474, Stop the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act; H.R. 447 / S. 97, Affordable and Safe Prescription Drug Importation Act; S. 61 / H.R. 478, Safe and Affordable Drugs from Canada Act of 2019; S. 102 / H.R. 465, Prescription Drug Price Relief Act of 2019; H.R.1478, Affordable Insulin Act of 2019; S. 3, Keeping Health Insurance Affordable Act of 2019; H.R 965 / S. 340, CREATES Act of 2019; H.R. 1332, Fair Care Act of 2019; S. 637, CURE High Drug Prices Act; H.R. 1499, Protecting Consumer Access to Generic Drugs Act of 2019; S. 657, A bill to amend title XXVII of the Public Health Service Act to establish requirements with respect to prescription drug benefits; S. 709, Prescription Drug Pricing Dashboard Act; S. 977, Transparent Drug Pricing Act of 2019; S. 1895, Lower Health Care Costs Act; H.R. 2296, FAIR Drug Pricing Act of 2019; H.R. 3947, the Competition Prescription Act of 2019; H.R. 2279, the Safe Step Act; H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, the Prescription Drug Pricing Reduction Act of 2019; H.R. 19 / S. 3129, the Lower Costs, More Cures Act of 2019; S. 4199, the Prescription Drug Pricing Reduction Act of 2020

Contacted: Office of Management & Budget (OMB); Drug Enforcement Administration (DEA); Defense, Dept of (DOD); Labor, Dept of (DOL); Medicare Payment Advisory Commission (MedPAC); Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); Food & Drug Administration (FDA); Small Business Administration (SBA); White House Office; Health & Human Services, Dept of (HHS); Internal Revenue Service (IRS); SENATE; Office of Natl Drug Control Policy (NDCP)

Bills named: S. 977 (116th), S. 97 (116th), H.R. 3 (116th), H.R. 478 (116th), H.R. 1499 (116th), H.R. 1478 (116th), H.R. 2296 (116th), H.R. 447 (116th), S. 4199 (116th), H.R. 3947 (116th), H.R. 1332 (116th), S. 61 (116th), S. 657 (116th), S. 474 (116th), H.R. 965 (116th), S. 637 (116th), H.R. 2279 (116th), S. 1895 (116th), S. 3 (116th), S. 3129 (116th), S. 340 (116th), H.R. 465 (116th), S. 102 (116th), S. 2543 (116th), S. 709 (116th), H.R. 19 (116th)

Taxation/Internal Revenue Code TAX

S. 172/H.R. 1398, Health Insurance Tax Relief Act of 2019; S. 215/H.R. 218, Death Tax Repeal Act of 2019; S. 1089/ H.R. 1922, Restoring Access to Medication Act of 2019; Final rule on Qualified Business Income Deduction; S. 1149/H.R. 216, the Main Street Tax Certainty Act of 2019; H.R. 6776, the Jumpstarting Our Businesses Success (JOBS) Credit Act; H.R. 6821 / S. 3612, the Small Business Expense Protection Act; H.R. 7079, the Clean Start: Back to Work Tax Credit Act

Contacted: Defense, Dept of (DOD); Government Accountability Office (GAO); White House Office; SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Drug Enforcement Administration (DEA); Labor, Dept of (DOL); Small Business Administration (SBA); Internal Revenue Service (IRS); Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); Office of Natl Drug Control Policy (NDCP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 7079 (116th), S. 172 (116th), S. 1089 (116th), S. 215 (116th), H.R. 1398 (116th), H.R. 218 (116th), S. 3612 (116th), H.R. 216 (116th), S. 1149 (116th), H.R. 1922 (116th), H.R. 6821 (116th), H.R. 6776 (116th)

Small Business SMB

H.R. 748 / S. 3548, the Coronavirus Aid, Relief, and Economic Security (CARES) Act; H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act; H.R. 266, the Paycheck Protection Program and Health Care Enhancement Act; H.R. 7010, the Paycheck Protection Program Flexibility Act of 2020; H.R. 2513, the Corporate Transparency Act of 2019; S. 4117/H.R. 7777, the Paycheck Protection Small Business Forgiveness Act; H.R. 8265, To amend the Small Business Act and the CARES Act to establish a program for second draw loans and make other modifications to the paycheck protection program, and for other purposes; S. 4321, Continuing Small Business Recovery and Paycheck Protection Program Act; S. 4773, Continuing the Paycheck Protection Program Act; S. 4775, the Delivering Immediate Relief to America's Families, Schools and Small Businesses Act

Contacted: Small Business Administration (SBA); Government Accountability Office (GAO); White House Office; Internal Revenue Service (IRS); Drug Enforcement Administration (DEA); Defense, Dept of (DOD); SENATE; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); Office of Natl Drug Control Policy (NDCP); Medicare Payment Advisory Commission (MedPAC)

Bills named: S. 3548 (116th), S. 4321 (116th), S. 4117 (116th), H.R. 6800 (116th), H.R. 2513 (116th), H.R. 8265 (116th), H.R. 266 (116th), H.R. 7010 (116th), H.R. 748 (116th), H.R. 7777 (116th), S. 4775 (116th), S. 4773 (116th)

Medicare/Medicaid MMM

H.R. 803 / S. 988, Improving Transparency and Accuracy in Medicare Part D Drug Spending Act; H.R. 1034 / S. 640, Phair Pricing Act of 2019; H.R. 1035, Prescription Drug Price Transparency Act, S. 475, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act, S. 476, Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act; H.R. 107, To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs; H.R.448 / S. 99, Medicare Drug Price Negotiation Act; H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019; H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019; H.R. 366, Insulin Access for All Act of 2019; S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019; S. 205 / H.R. 937, Right Rebate Act of 2019; H.R. 1046 / S. 377, Medicare Negotiation and Competitive Licensing Act of 2019; H.R. 1781 / S. 801, the Payment Commission Data Act of 2019; H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act of 2019; H.R. 2115, To amend title XI of the Social Security Act to provide greater transparency of discounts provided by drug manufacturers; Proposed rule, "Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses, CMS-4180-P"; Proposed rule, "Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees, OIG-0936-P"; Proposed rule, Medicaid Program; Medicaid and Childrens Health Insurance Plan (CHIP) Managed Care - CMS-2408-P; H.R. 1323, Rural Hospital Frontier Fairness Act; S. 551, REFUND Act of 2019; S. 691, Medicare Extra Rx HELP Act of 2019; S. 773, Telehealth Innovation and Improvement Act of 2019; S. 814, Expanding Access to Diabetes Self-Management Training Act of 2019; H.R. 1384 / S. 1129, Medicare for All Act of 2019; H.R. 3417, The Beneficiary Education Tools, Telehealth, and Extenders Reauthorization Act of 2019; H.R. 3408, Shop Rx Act of 2019; S. 1384, Prescription Drug Rebate Reform Act of 2019; H.R. 2113, Prescription Drug STAR Act; H.R. 2115, Public Disclosure of Drug Discounts Act S. 2447, the Phair Relief Act; S. 2771, the Protecting Home Oxygen and Medical Equipment Act of 2019; S. 1861 / H.R. 3924, the Streamlining Part D Appeals Process Act; H.R. 4946, the Ensuring Seniors Access to Local Pharmacies Act of 2019; H.R. 5281, the Drug Price Transparency in Medicaid Act of 2019; H.R. 5442, the Lowest Price for Patients Act; Report language for H.R.1865, the Further Consolidated Appropriations Act; Pharmacist Provider Status draft legislation

Contacted: White House Office; Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); Drug Enforcement Administration (DEA); Defense, Dept of (DOD); Small Business Administration (SBA); SENATE; Food & Drug Administration (FDA); Substance Abuse & Mental Health Services Administration (SAMHSA); Labor, Dept of (DOL); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Internal Revenue Service (IRS)

Bills named: S. 475 (116th), H.R. 2115 (116th), S. 377 (116th), S. 476 (116th), S. 1861 (116th), S. 640 (116th), S. 691 (116th), H.R. 1346 (116th), S. 814 (116th), H.R. 2113 (116th), H.R. 1034 (116th), H.R. 1323 (116th), H.R. 448 (116th), H.R. 366 (116th), S. 99 (116th), S. 773 (116th), H.R. 1384 (116th), S. 988 (116th), S. 1384 (116th), S. 801 (116th), S. 1129 (116th), H.R. 1865 (116th), S. 205 (116th), H.R. 803 (116th), H.R. 5442 (116th), S. 551 (116th), H.R. 5281 (116th), S. 62 (116th), S. 2447 (116th), H.R. 3408 (116th), H.R. 4946 (116th), H.R. 1035 (116th), H.R. 275 (116th), S. 2771 (116th), H.R. 1781 (116th), H.R. 107 (116th), H.R. 937 (116th), H.R. 3417 (116th), H.R. 1046 (116th), H.R. 3924 (116th)

Pharmacy PHA

H.R. 1959, Preserving Patient Access to Compounded Medications Act of 2019; H.R. 2376 / S. 1227, Prescription Pricing for the People Act of 2019; H.R. 3223 / S. 1532, Pharmacy Benefit Manager Accountability Study Act of 2019; H.R. 5198, the Patients' Right to Know Their Medication Act of 2019; H.R. 5304, the PBM Transparency in Prescription Drug Costs Act; Draft Long Term Care pharmacy definition legislation

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); SENATE; Centers For Medicare and Medicaid Services (CMS); Office of Natl Drug Control Policy (NDCP); Government Accountability Office (GAO); Labor, Dept of (DOL); Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); Defense, Dept of (DOD); White House Office; Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Internal Revenue Service (IRS); Small Business Administration (SBA); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC)

Bills named: H.R. 3223 (116th), H.R. 2376 (116th), H.R. 1959 (116th), S. 1532 (116th), H.R. 5304 (116th), H.R. 5198 (116th), S. 1227 (116th)